News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
238 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (103)
4 (175)
5 (247)
6 (211)
7 (266)
8 (238)
11 (138)
12 (206)
13 (219)
14 (240)
15 (174)
18 (169)
19 (181)
20 (151)
21 (145)
22 (81)
23 (1)
25 (165)
26 (155)
27 (94)
28 (19)
29 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
23
25
26
27
28
29
Editorial
Lilly vs. Novo: The ‘He Said, She Said’ Row About Catalent’s GLP-1 Work
With Novo Holdings’ $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.
November 8, 2024
·
4 min read
·
Greg Slabodkin
China
Pfizer Makes $1B Commitment in China to Boost Innovation, Targets Chinese Market
The five-year investment will go toward the construction of a new R&D facility in Beijing to develop innovative therapies and integrate the world’s second most populated country into the company’s global strategy.
November 8, 2024
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
Leqembi’s sales continue to be underwhelming, according to analysts, who contend the companies’ Alzheimer’s disease therapy is being held back by barriers such as coverage, infusion centers and time to diagnosis.
November 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Ocugen Secures $30 Million in Debt Funding
November 8, 2024
·
5 min read
Press Releases
Sobi to present new data across its immunology portfolio at the ACR Convergence 2024
November 8, 2024
·
6 min read
Press Releases
SpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting
November 8, 2024
·
16 min read
Press Releases
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 8, 2024
·
17 min read
Press Releases
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
November 8, 2024
·
44 min read
Press Releases
SynOx Therapeutics Further Strengthens Executive Team with Appointments of U.S.-Based Chief Medical Officer and Chief Commercial Officer
November 8, 2024
·
6 min read
Press Releases
Viatris Reports Third Quarter Financial Results for 2024
November 8, 2024
·
47 min read
1 of 24
Next
